Evidence map›Paper›PMID 42422746›Full record

ArticleFrontiers in microbiology2026

Detection of ongoing asymptomatic

Mengyu Li, Jizong Li, Lan Yang, Zhiwei Li, Dayong Gu, Xiaoting Xu, Yezi Liu, Xiaoyu Li, Wei Wang, Bin Li and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mengyu Li *School of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, China.
Jizong Li *Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology Ministry of Agriculture, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.
Lan YangDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Zhiwei LiClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Dayong GuDepartment of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen University, Shenzhen, China.
Xiaoting XuDepartment of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yezi LiuClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Xiaoyu LiSchool of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, China.
Wei WangInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology Ministry of Agriculture, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.
Bin LiInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology Ministry of Agriculture, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.
Hongwei MaSchool of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asymptomatic hosts can shed pathogens without showing clinical symptoms, making them invisible to routine screenings and potent drivers of pathogen dissemination and epidemic outbreaks. The lack of reliable, cost-effective tools for large-scale identification of asymptomatic infections hampers early intervention and control strategies. Methods: We improved the IgG serodynamics-based epitope discovery method by integrating clustering and high-level analysis, which helped us identify linear epitopes with immunogenicity from a large number of candidate epitopes. Epitopes were filtered using negative sera identified by virus neutralization tests (VNT) to eliminate highly antigenic probes. These remaining low antigenicity probes were used to construct a protein-peptide hybrid microarray (PPHM Results: The PPHM Conclusion: The study provides a novel, specific, and practical platform for detecting asymptomatic PDCoV infections based on serological TPI signatures. It offers early warning and disease prevention strategies in livestock and establishes a framework for future monitoring of potential interspecies transmission.

Indexed as

asymptomatic infectionsimmunogenicityPDCoVtransiently produced IgGszoonotic

Identifiers

PMID42422746
PMCPMC13341950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.